Pim-1 Kinase Regulating Dynamics Related Protein 1 Mediates Sevoflurane Postconditioning-induced Cardioprotection

被引:11
|
作者
Liu, Jin-Dong [1 ,2 ]
Chen, Hui-Juan [2 ]
Wang, Da-Liang [2 ]
Wang, Hui [2 ]
Deng, Qian [1 ,2 ]
机构
[1] Xuzhou Med Univ, Affiliated Hosp, Dept Anesthesiol, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Anesthesiol, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China
关键词
Cardioprotection; Ischemia-reperfusion Injury; Mitochondria; Pim-1; Postconditioning; Sevoflurane; MITOCHONDRIAL FISSION; MYOCARDIAL-INFARCTION; THERAPEUTIC TARGET; REPERFUSION INJURY; DRP1; RECRUITMENT; ACTIVATION; HEART; APOPTOSIS; STRESS; CELLS;
D O I
10.4103/0366-6999.198922
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is well documented that sevoflurane postconditioning (SP) has a significant myocardial protection effect. However, the mechanisms underlying SP are still unclear. In the present study, we investigated the hypothesis that the Pim-1 kinase played a key role in SP-induced cardioprotection by regulating dynamics-related protein 1 (Drp1). Methods: A Langendorff model was used in this study. Seventy-two rats were randomly assigned into six groups as follows: CON group, ischemia reperfusion (I/R) group, SP group, SP+proto-oncogene serine/threonine-protein kinase 1 (Pim-1) inhibitor II group, SP+dimethylsufoxide group, and Pim-1 inhibitor II group (n = 12, each). Hemodynamic parameters and infarct size were measured to reflect the extent of myocardial I/R injury. The expressions of Pim-1, B-cell leukemia/lymphoma 2 (Bcl-2) and cytochrome C (Cyt C) in cytoplasm and mitochondria, the Drp1 in mitochondria, and the total Drp1 and p-Drp1(ser637) were measured by Western blotting. In addition, transmission electron microscope was used to observe mitochondrial morphology. The experiment began in October 2014 and continued until July 2016. Results: SP improved myocardial I/R injury-induced hemodynamic parametric changes, cardiac function, and preserved mitochondrial phenotype and decreased myocardial infarct size (24.49 +/- 1.72% in Sev group compared with 41.98 +/- 4.37% in I/R group; P < 0.05). However, Pim-1 inhibitor II significantly (P < 0.05) abolished the protective effect of SP. Western blotting analysis demonstrated that, compared with I/R group, the expression of Pim-1 and Bcl-2 in cytoplasm and mitochondria as well as the total p-Drp1ser637 in Sev group (P < 0.05) were upregulated. Meanwhile, SP inhibited Drp1 compartmentalization to the mitochondria followed by a reduction in the release of Cyt C. Pretreatment with Pim-1 inhibitor II significantly (P < 0.05) abolished SP-induced Pim-1/p-Drp1(ser637) signaling activation. Conclusions: These findings suggested that SP could attenuate myocardial ischemia-reperfusion injury by increasing the expression of the Pim-1 kinase. Upregulation of Pim-1 might phosphorylate Drp1 and prevent extensive mitochondrial fission through Drp1 cytosolic sequestration.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 50 条
  • [41] Phosphorylation of DEPDC5 by the Pim-1 protein kinase, a cancer driver, stimulates mTORC1 activity by regulating the DEPDC5-Rag GTPase interaction.
    Padi, Sathish K. R.
    Singh, Neha
    Mouneimne, Ghassan
    Kraft, Andrew S.
    Okumura, Koichi
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 24 - 24
  • [42] Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer
    Sharma, Anushka
    Dubey, Rahul
    Asati, Vikas
    Baweja, Gurkaran Singh
    Gupta, Shankar
    Asati, Vivek
    MOLECULAR DIVERSITY, 2024,
  • [43] Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa
    Keen, TJ
    Hims, MM
    McKie, AB
    Moore, AT
    Doran, RM
    Mackey, DA
    Mansfield, DC
    Mueller, RF
    Bhattacharya, SS
    Bird, AC
    Markham, AF
    Inglehearn, CF
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (04) : 245 - 249
  • [44] Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa
    T Jeffrey Keen
    Matthew M Hims
    Arthur B McKie
    Anthony T Moore
    Rob M Doran
    David A Mackey
    David C Mansfield
    Robert F Mueller
    Shomi S Bhattacharya
    Alan C Bird
    Alexander F Markham
    Chris F Inglehearn
    European Journal of Human Genetics, 2002, 10 : 245 - 249
  • [45] CHARACTERIZATION OF THE HUMAN PIM-1 GENE - A PUTATIVE PROTOONCOGENE CODING FOR A TISSUE SPECIFIC MEMBER OF THE PROTEIN-KINASE FAMILY
    MEEKER, TC
    NAGARAJAN, L
    ARRUSHDI, A
    ROVERA, G
    HUEBNER, K
    CROCE, CM
    ONCOGENE RESEARCH, 1987, 1 (01) : 87 - 101
  • [46] Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant returns pigmentosa
    Inglehearn, CF
    McKie, AB
    Hims, MM
    Moore, AT
    Doran, RM
    Mackey, DA
    Mansfield, DC
    Bhattacharya, SS
    Bird, AC
    Keen, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U179 - U179
  • [47] The Pim-1 protein kinase decreases p27 protein half-life and increases prostate epithelial cell migration
    Cen, Bo
    Zemskova, Marina
    Beharry, Zanna
    Smith, Charles
    Kraft, Andrew
    CANCER RESEARCH, 2009, 69
  • [48] The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
    Xu, Dapeng
    Allsop, Stephen A.
    Witherspoon, Sam M.
    Snider, Jared L.
    Yeh, Jen Jen
    Fiordalisi, James J.
    White, Catherine D.
    Williams, Daniel
    Cox, Adrienne D.
    Baines, Antonio T.
    CARCINOGENESIS, 2011, 32 (04) : 488 - 495
  • [49] Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site
    Aho, TLT
    Sandholm, J
    Peltola, KJ
    Mankonen, HP
    Lilly, M
    Koskinen, PJ
    FEBS LETTERS, 2004, 571 (1-3): : 43 - 49
  • [50] THE PIM-1 ONCOGENE ENCODES 2 RELATED PROTEIN-SERINE THREONINE KINASES BY ALTERNATIVE INITIATION AT AUG AND CUG
    SARIS, CJM
    DOMEN, J
    BERNS, A
    EMBO JOURNAL, 1991, 10 (03): : 655 - 664